Key result
Intraoperative VA-ECMO in lung transplantation is not associated with lower mortality but lengthens ICU stay.
Why the study?
Intraoperative VA-ECMO is increasingly used during lung transplantation for cardiopulmonary support, yet its effect on postoperative outcomes remains incompletely understood.
Cohort (n=105)
No
Answers are grounded in this paper and cite their sources.
Supports VA-ECMO safety in lung transplant without excess complications; leaves open randomized trials for optimal use and long-term outcomes.
Background Intraoperative Veno-Arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used during lung transplantation to provide cardiopulmonary support, yet its effect on postoperative outcomes remains incompletely understood. Methods We performed a retrospective cohort study of 105 adult patients who underwent bilateral sequential lung transplantation at UT Southwestern Medical Center between January 1, 2023, and December 31, 2024. Patients were stratified into two groups based on need for intraoperative support: intraoperative VA-ECMO and non-ECMO. Demographic, anthropometric, and preoperative measurements were collected. Surgery duration, intraoperative blood products given, postoperative complications, and survival were also included. Propensity-score overlap-weighting was used to account for baseline differences between groups and adjust for measured confounders. Results In propensity-score overlap-weighted analyses, intraoperative VA-ECMO use was not associated with statistically significant differences in primary graft dysfunction (OR, 0.90; 95% CI, 0.21-3.88; p=0.89), hemothorax (OR, 4.59; 95% CI, 0.51-41.35; p=0.17), thromboembolic events (OR, 1.38; 95% CI, 0.52-3.66; p=0.51), or mortality (HR, 0.62; 95% CI, 0.20-1.87; p=0.39) compared with transplantation without intraoperative ECMO. ICU length of stay was longer in the ECMO group (95% CI, 1.09-2.77; p=0.02). Kaplan-Meier overall survival demonstrated similar mortality between groups (log-rank p=0.19) Conclusion In this retrospective observational study, intraoperative VA-ECMO during lung transplantation was associated with broadly similar major clinical outcomes, with the exception of longer ICU length of stay. Given the individualized nature of ECMO selection and potential for residual confounding, these findings do not establish a causal effect of intraoperative ECMO on postoperative outcomes.
No takes yet. Share an insight, caveat, or question.
Castro et al. (2026) conducted a cohort in Bilateral sequential lung transplantation (n=105). Intraoperative Veno-Arterial extracorporeal membrane oxygenation (VA-ECMO) vs. Transplantation without intraoperative ECMO was evaluated on Mortality (HR 0.62, 95% CI 0.20-1.87, p=0.39). Intraoperative VA-ECMO during lung transplantation was not associated with mortality or primary graft dysfunction, but increased ICU stay.
Synapse has enriched 10 related papers. Consider them for comparative context: